MAZE

Maze Therapeutics

74 hedge funds and large institutions have $477M invested in Maze Therapeutics in 2025 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TGI
1
TRV GP IV
Massachusetts
$74.5M
FLSM
2
Frazier Life Sciences Management
California
$56M
AVM
3
Arch Venture Management
Illinois
$50.6M
DTC
4
Deep Track Capital
Connecticut
$48.5M
MCMC
5
Matrix Capital Management Company
New Hampshire
$30.5M
AI
6
Alphabet Inc
California
$29.6M
FCMI
7
Foresite Capital Management IV
California
$25.9M
ACM
8
AH Capital Management
California
$20.9M
Janus Henderson Group
9
Janus Henderson Group
United Kingdom
$17.3M
GCGM
10
General Catalyst Group Management
Massachusetts
$12.7M
TGV
11
TRV GP V
Massachusetts
$11.7M
WP
12
Woodline Partners
California
$11.5M
CC
13
Casdin Capital
New York
$9.31M
HMC
14
Harvard Management Company
Massachusetts
$7.82M
BlackRock
15
BlackRock
New York
$7.54M
LGM
16
Logos Global Management
California
$7.51M
Fidelity Investments
17
Fidelity Investments
Massachusetts
$6.8M
Bessemer Group
18
Bessemer Group
New Jersey
$5.91M
HA
19
HHLR Advisors
Cayman Islands
$5.61M
Vanguard Group
20
Vanguard Group
Pennsylvania
$5.15M
SFM
21
Sphera Funds Management
Israel
$4.37M
FCMV
22
Foresite Capital Management V
California
$4.24M
IC
23
Ikarian Capital
Texas
$3.22M
Geode Capital Management
24
Geode Capital Management
Massachusetts
$2.84M
DCM
25
Driehaus Capital Management
Illinois
$2.37M